Claritev Corporation (CTEV): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Claritev Health (CTEV)

The P/S ratio of Claritev Corp (CTEV) clearly demonstrates the market valuation of Claritev Corp, where the 0.50 metric serves as the target level. Digital underwriting ensures the stability of profits and cash flow. Business efficiency relies on analytics to optimize insurance payouts. The full digitalization of services eliminates physical risks, limiting costs solely to the regulated updating of IT infrastructure.

Claritev Health (CTEV): Market Cap to Revenue from 03/01/2025 to 11/13/2026

Claritev Inc. (CTEV) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Stock Price claritev.com|CTEV - Price Target Chart
- stock exchange capitalization data:
Market Value Claritev Inc.|CTEV - Enterprise Value
- book capitalization indicators:
Net Assets per Share Claritev|CTEV - Company Net Assets|Market Cap to Book Value Multiple claritev.com|CTEV - Company Total Assets
- debt obligations and liquidity statistics:
Debt to Capital Claritev Corp|CTEV - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Claritev Health|CTEV - Company Total Debt|Debt to Net Assets Ratio Claritev Inc.|CTEV - Company Long-Term Debts|Company Current Liabilities Claritev|Immediate Liquidity claritev.com
- net income and valuation ratios data:
CTEV - Company Net Income|Expected Net Income Claritev Corp|CTEV - Price to Earnings Ratio|Price to Expected Earnings Ratio Claritev Corporation|CTEV - PEG Multiple|Enterprise Value to EBITDA Ratio Claritev Inc.|CTEV - Operating profit before deduction of amortization|Earnings per share for the last four quarters Claritev|CTEV - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months claritev.com|CTEV - Net earnings per share growth this year|Net earnings per share growth forecast for next year Claritev Corp
- sales revenue and business income indicators:
CTEV - Company Revenue|Company Future Sales Volume claritev.com|CTEV - P/S Multiple|Market Cap to Future Revenue Ratio Claritev Inc.
Summary company analytics:claritev.com, CTEV
Mass-produced product of Claritev Health

For Claritev Corp (CTEV), the market capitalization-to-annual revenue ratio serves as a valuation filter amid regulatory risks within the US insurance system. Analyzing P/S fluctuations helps determine the extent to which the current share price is justified by the company's actual earnings, enabling investors to distinguish fundamental asset undervaluation from hidden threats to the issuer's operational stability.

Competing companies

P/S Multiple unitedhealthgroup.com (UNH)|Price-to-Revenue Ratio Cigna CI|Market Capitalization-to-Revenue Ratio AFL|Humana Health - P/S Multiple|Price-to-Revenue Coefficient Centene Health CNC|MOH (Molina Healthcare, Inc.) - Market Cap to Revenue|MMS: Market Cap to Sales Volume|OSCR (Oscar Health) - P/S Multiple|Price to Sales Clover Health Investments, Corp. CLOV|Market Cap to Revenue YB (Yuanbao Insurance)|Price-to-Revenue Ratio HIT (healthintech.com)|eHealth - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio GOCO|NeueHealth Corp - P/S Multiple|Reliance Global Group Inc (RELI) - Market Cap to Revenue|LifeWallet (LIFW) - Price-to-Revenue Ratio|Price to Sales MultiPlan Inc. (MPLN)